1. Binding Kinetics Survey of the Drugged Kinome
- Author
-
Benedict-Tilman Berger, Felix Schiele, Cornelia Preusse, Paula A. Marin Zapata, Stephan Menz, Victoria Georgi, Hans Briem, Amaury Ernesto Fernandez-Montalvan, James D Vasta, Matthew B. Robers, Michael Brands, Andreas Steffen, and Stefan Knapp
- Subjects
0301 basic medicine ,In silico ,Kinetics ,Computational biology ,01 natural sciences ,Biochemistry ,Catalysis ,03 medical and health sciences ,Colloid and Surface Chemistry ,Drug Discovery ,Humans ,Kinome ,Binding site ,Protein Kinase Inhibitors ,ADME ,Binding Sites ,Molecular Structure ,010405 organic chemistry ,Chemistry ,Drug discovery ,Phosphotransferases ,General Chemistry ,Receptor–ligand kinetics ,0104 chemical sciences ,030104 developmental biology ,Cheminformatics - Abstract
Target residence time is emerging as an important optimization parameter in drug discovery, yet target and off-target engagement dynamics have not been clearly linked to the clinical performance of drugs. Here we developed high-throughput binding kinetics assays to characterize the interactions of 270 protein kinase inhibitors with 40 clinically relevant targets. Analysis of the results revealed that on-rates are better correlated with affinity than off-rates and that the fraction of slowly dissociating drug-target complexes increases from early/preclinical to late stage and FDA-approved compounds, suggesting distinct contributions by each parameter to clinical success. Combining binding parameters with PK/ADME properties, we illustrate in silico and in cells how kinetic selectivity could be exploited as an optimization strategy. Furthermore, using bio- and chemoinformatics we uncovered structural features influencing rate constants. Our results underscore the value of binding kinetics information in rational drug design and provide a resource for future studies on this subject.
- Published
- 2018
- Full Text
- View/download PDF